204 related articles for article (PubMed ID: 25754718)
1. Hypersensitivity to biological agents-updated diagnosis, management, and treatment.
Galvão VR; Castells MC
J Allergy Clin Immunol Pract; 2015; 3(2):175-85; quiz 186. PubMed ID: 25754718
[TBL] [Abstract][Full Text] [Related]
2. Benzodiazepine Allergy With Anesthesia Administration: A Review of Current Literature.
Haybarger E; Young AS; Giovannitti JA
Anesth Prog; 2016; 63(3):160-7. PubMed ID: 27585420
[TBL] [Abstract][Full Text] [Related]
3. Recognizing Drug Hypersensitivity in Pigmented Skin.
Lehloenya RJ; Phillips EJ; Pasieka HB; Peter J
Immunol Allergy Clin North Am; 2022 May; 42(2):219-238. PubMed ID: 35469616
[TBL] [Abstract][Full Text] [Related]
4. Case series of sebelipase alfa hypersensitivity reactions and successful sebelipase alfa rapid desensitization.
Huffaker MF; Liu AY; Enns GM; Vijay S; Amor AJ; Adkinson NF
JIMD Rep; 2019 Sep; 49(1):30-36. PubMed ID: 31497479
[TBL] [Abstract][Full Text] [Related]
5. Hypersensitivity and immunologic reactions to biologics: opportunities for the allergist.
Khan DA
Ann Allergy Asthma Immunol; 2016 Aug; 117(2):115-20. PubMed ID: 27499538
[TBL] [Abstract][Full Text] [Related]
6. Anaphylaxis to chemotherapy and monoclonal antibodies.
Castells MC
Immunol Allergy Clin North Am; 2015 May; 35(2):335-48. PubMed ID: 25841555
[TBL] [Abstract][Full Text] [Related]
7. Adverse Reactions to Biologic Therapy.
Patel SV; Khan DA
Immunol Allergy Clin North Am; 2017 May; 37(2):397-412. PubMed ID: 28366484
[TBL] [Abstract][Full Text] [Related]
8. Hypersensitivity reactions during treatment with biological agents.
Puxeddu I; Caltran E; Rocchi V; Del Corso I; Tavoni A; Migliorini P
Clin Exp Rheumatol; 2016; 34(1):129-32. PubMed ID: 26751942
[TBL] [Abstract][Full Text] [Related]
9. New systemic agents in dermatology with respect to fertility, pregnancy, and lactation.
Grunewald S; Jank A
J Dtsch Dermatol Ges; 2015 Apr; 13(4):277-89; quiz 290. PubMed ID: 25819232
[TBL] [Abstract][Full Text] [Related]
10. A pilot study of omalizumab in eosinophilic esophagitis.
Loizou D; Enav B; Komlodi-Pasztor E; Hider P; Kim-Chang J; Noonan L; Taber T; Kaushal S; Limgala R; Brown M; Gupta R; Balba N; Goker-Alpan O; Khojah A; Alpan O
PLoS One; 2015; 10(3):e0113483. PubMed ID: 25789989
[TBL] [Abstract][Full Text] [Related]
11. Monitoring of omalizumab therapy by measuring free IgE using a bedside immunoassay.
Steiss JO; Schmidt A; Rudloff S
Clin Lab; 2015; 61(1-2):31-7. PubMed ID: 25807635
[TBL] [Abstract][Full Text] [Related]
12. Longitudinal study of the expression of FcεRI and IgE on basophils and dendritic cells in association with basophil function in two patients with severe allergic asthma treated with Omalizumab.
Pereira Santos MC; Campos Melo A; Caetano A; Caiado J; Mendes A; Pereira Barbosa M; Branco Ferreira M
Eur Ann Allergy Clin Immunol; 2015 Mar; 47(2):38-40. PubMed ID: 25781192
[TBL] [Abstract][Full Text] [Related]
13. Reduced dose of tocilizumab for the maintenance of remission in patients with rheumatoid arthritis: a clinical experience.
Epis O; Casu C; Belloli L; Schito E; Filippini D; Muscarà M; Bruschi E
Rheumatol Int; 2015 Sep; 35(9):1569-70. PubMed ID: 25773656
[No Abstract] [Full Text] [Related]
14. Development of eosinophilic granulomatosis with poliangiitis (Churg-Strauss syndrome) and brain tumor in a patient after more than 7 years of omalizumab use: A case report.
Borekci S; Aydin O; Hatemi G; Gemicioglu B
Int J Immunopathol Pharmacol; 2015 Mar; 28(1):134-7. PubMed ID: 25816417
[TBL] [Abstract][Full Text] [Related]
15. Rituximab therapy for ankylosing spondylitis associated to demyelinating disease of the central nervous system.
Heredia S; Aparicio M; Armengol E; Juanola X
Joint Bone Spine; 2016 Jan; 83(1):105-6. PubMed ID: 25776441
[No Abstract] [Full Text] [Related]
16. Patterns of use and dosing of tocilizumab in the treatment of patients with rheumatoid arthritis in routine clinical practice: the ACT-LIFE study.
Balsa A; Tovar Beltrán JV; Cáliz Cáliz R; Mateo Bernardo I; García-Vicuña R; Rodríguez-Gómez M; Belmonte Serrano MA; Marras C; Loza Cortina E; Pérez-Pampin E; Vila V
Rheumatol Int; 2015 Sep; 35(9):1525-34. PubMed ID: 25773655
[TBL] [Abstract][Full Text] [Related]
17. Mast Cell Activation Disease and Microbiotic Interactions.
Afrin LB; Khoruts A
Clin Ther; 2015 May; 37(5):941-53. PubMed ID: 25773459
[TBL] [Abstract][Full Text] [Related]
18. Rheumatoid arthritis: an evolutionary force in biologics.
Brown PM; Isaacs JD
Curr Pharm Des; 2015; 21(17):2170-8. PubMed ID: 25760301
[TBL] [Abstract][Full Text] [Related]
19. Diagnoses and Management of Drug Hypersensitivity and Anaphylaxis in Cancer and Chronic Inflammatory Diseases: Reactions to Taxanes and Monoclonal Antibodies.
Bonamichi-Santos R; Castells M
Clin Rev Allergy Immunol; 2018 Jun; 54(3):375-385. PubMed ID: 27277133
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
